(Alliance News) - Mereo BioPharma Group PLC on Tuesday posted a slightly narrowed loss for the first half of 2019 on a gain from its OncoMed Pharmaceuticals Inc acquisition, as well as lower in at Read More
(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Corporate Development John Richard, all purchased Read More
(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday reported positive six-month data for its anti-sclerostin antibody, BPS-804, in the treatment of adult patients with osteogenesis were Read More
LONDON (Alliance News) - Mereo Biopharma PLC said Thursday that Non-Executive Director Peter Bains purchased around GBP42,750 in stock in a deal on Tuesday.Bains bought 47,500 shares at a Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday said its loss narrowed in 2018 following the completion of several product trials.The clinical stage biopharmaceutical company a Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC on Tuesday said its all-stock merger with OncoMed Pharmaceuticals Inc is now complete.OncoMed's shareholders approved the deal on last Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday said OncoMed Pharmaceuticals Inc shareholders have approved the merger of the two companies.Mereo BioPharma, a clinical stage Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC said on Monday it has concluded an end of Phase Two meeting with the US Food & Drug Administration regarding acumapimod as a treatment for of Read More
LONDON (Alliance News) - Mereo BioPharma Group PLC on Friday said it has now received support agreements in respect of 21.1% of OncoMed Pharmaceuticals Inc's shares and expects to complete the Read More
